Cargando…
Cancer therapy in mice using a pure population of CD8(+) T cell specific to the AH1 tumor rejection antigen
There is a growing interest in the use of patient-derived T cells for the treatment of various types of malignancies. The expansion of a polyclonal and polyspecific population of tumor-reactive T cells, with a subsequent infusion into the same donor patient, has been implemented, sometimes with posi...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505334/ https://www.ncbi.nlm.nih.gov/pubmed/33796916 http://dx.doi.org/10.1007/s00262-021-02912-9 |